Daily non-political popular news in brief.

International HIV/AIDS trial finds risks increase on episodic antiretroviral therapy

Results from one of the largest HIV/AIDS treatment trials ever conducted show that a specific strategy of interrupting antiretroviral therapy more than doubles the risk of AIDS or death from any cause. In the study, the investigators used two predetermined levels of CD4+ T cells, the primary immune cell targeted by HIV, to guide them in respectively suspending or restarting the study participants on antiretroviral therapy.

Read more »

Keywords: international, hiv, aids, trial, risks, episodic, antiretroviral, therapy, aid, risk

« Previous | Next »

Similar news on "International HIV/AIDS trial finds risks increase on episodic antiretroviral therapy":

1. Study shows interruption of antiretroviral therapy increases risk of disease and death
   11-30-2006 · EurekAlert!
   Findings from one of the largest HIV/AIDS therapy studies show that a specific strategy of interrupting antiretroviral therapy more than doubles the risk of AIDS or death from any cause. Researchers affiliated with the Mailman School of Public Health led a large multi-center international study, known as Strategies for Management of Anti-Retroviral Therapies, or SMART, comparing two treatment strategies for people with human immunodeficiency virus. Findings demonstrate the value of continuous antiretroviral therapy.
   Similar news · Read more »
   
2. Experts urge strongest isolation for new drug-resistant tuberculosis cases appearing in South Africa
   01-22-2007 · EurekAlert!
   Medical ethics and other experts say tough isolation measures, involuntary if need be, are justified to contain a very deadly, highly-contagious and drug-resistant mutant strains of tuberculosis and to prevent "a potentially explosive international health crisis" brewing most dangerously at the epicenter of South Africa's HIV/AIDS epidemic. The new TB variations now defeat many of the world's existing drugs and pose "extreme risk."
   Similar news · Read more »
   
3. MGH study examines impact of infection with both HIV and hepatitis C virus
   12-11-2006 · EurekAlert!
   In a report in the December issue of PLOS Medicine, a group of researchers from the Partners AIDS Research Center at Massachusetts General Hospital report one of the first studies of how HIV infection impacts immune system functions involved with hepatitis C virus control. Their findings suggest that beginning antiretroviral therapy earlier than is generally recommended may help preserve HCV control in patients infected with both viruses.
   Similar news · Read more »
   
4. Study: Directly observed HIV therapy for children is promising
   05-31-2007 · EurekAlert!
   The first study in the developing world of directly observed antiretroviral therapy for HIV-infected children shows this form of treatment is an inexpensive, effective way to ensure that children take life-saving medications. Researchers at the Warren Alpert Medical School of Brown University, together with Maryknoll, the international Catholic charity, conducted the study. Results are published in the June issue of the American Journal of Public Health.
   Similar news · Read more »
   
5. International AIDS Vaccine Initiative (IAVI) statement on male circumcision
   12-14-2006 · EurekAlert!
   The International AIDS Vaccine Initiative (IAVI) issued this statement today following a National Institutes of Health (NIH) decision to end two clinical trials of adult male circumcision in Uganda and Kenya. The NIH's Data Safety and Monitoring Board (DSMB), reviewing interim data, found that medically performed circumcision significantly protected men in the trial from HIV infection.
   Similar news · Read more »
   
6. Study finds strong demand for HIV meds after high-risk sex
   11-08-2007 · EurekAlert!
   People who do not have HIV but seek antiretroviral medications following high-risk sexual encounters are very likely to complete the full month-long drug regimen, according to a new UCLA AIDS Institute study. Moreover, there is a strong demand for publicly available post-exposure prophylaxis among high-risk populations in Los Angeles County. Based on these findings, the researchers recommend that Los Angeles County make post-exposure HIV prophylaxis available to citizens who have engaged in high-risk sex.
   Similar news · Read more »
   
7. Phase I study of novel gene therapy for HIV
   11-06-2006 · EurekAlert!
   The results are in for Phase I clinical trials of a gene therapy for AIDS. The trial was conducted at U-Penn where five patients with chronic HIV who had failed prior therapies were given a one-time infusion. They all tolerated the therapy and showed improved immune system response. This is the first publication of an effective gene therapy for AIDS to show positive clinical results in the peer review literature.
   Similar news · Read more »
   
8. Fighting HIV with HIV
   11-06-2006 · EurekAlert!
   Researchers at the University of Pennsylvania School of Medicine report the first clinical test of a new gene therapy based on a disabled AIDS virus carrying genetic material that inhibits HIV replication. For the first application of the new vector five subjects with chronic HIV infection who had failed to respond to at least two antiretroviral regimens were given a single infusion of their own immune cells that had been genetically modified for HIV resistance.
   Similar news · Read more »
   
9. Circumcision for prevention of HIV: new analysis demonstrates cost-effectiveness
   12-25-2006 · EurekAlert!
   A team of researchers who conducted a landmark trial in Orange Farm, South Africa, which concluded that male circumcision can substantially reduce the risk of becoming infected with HIV, have now studied the economic aspects of this approach to preventing HIV/AIDS. Their new research, published in PLoS Medicine, suggests that circumcision could reduce the cost of health care in South Africa (and other sub-Saharan Countries), mainly through savings on the cost of HIV treatment.
   Similar news · Read more »
   
10. Global Fund must fund salaries of health workers to deliver HIV, TB and malaria treatments
    04-16-2007 · EurekAlert!
    In this week's PLoS Medicine, a team of international health experts issue a bold call to the Global Fund to Fight AIDS, TB and Malaria: fund the salaries of health workers or else risk a situation in which medicines for these three diseases are made available in poor countries but there are no health professionals to deliver them.
    Similar news · Read more »